Thursday, 1 July 2010
12:45 – 14:15
ColoRectal Cancer; Liver Metastases - Drug-Eluting Bead, Irinotecan (DEBIRI), optimising localised treatment within systemic therapy
Supported by: Biocompatibles UK Ltd
Room 111-112
Patient-driven treatment strategies in CRC
Supported by: F. Hoffmann-La Roche
Room 116-117
Friday, 2 July 2010
13:15 – 14:45
Personalizing treatment – A new standard treatment to prolong overall survival in mCRC
Supported by: Merck Serono
Room 111-112
Radioembolisation: Who, What, When and How
Supported by: Sirtex Medical Europe GmbH
Room 113-115
Transforming the treatment of gastric cancer
Supported by: F. Hoffmann-La Roche
Room 116-117
Saturday, 3 July 2010
13:15 – 14:45
ESO Cancer Observatory
Supported by European School of Oncology
Room 111-112
Challenges in the Management of mCRC: Treatment Options under Scrutiny
Supported by: Amgen (EUROPE) GmbH
Room 116-117
Times and location are subject to change.
|
